Protein SSX2 (19-34)

Protein SSX2 (19-34) is a synthetic peptide fragment corresponding to amino acids 19 through 34 of the SSX2 protein, a member of the synovial sarcoma, X breakpoint (SSX) family of cancer-testis antigens. As a peptide compound, it is characterized by its defined sequence and structural properties, making it a valuable tool in the study of protein-protein interactions, epitope mapping, and immune response mechanisms. The SSX2 protein is known to play roles in chromatin remodeling and gene regulation, particularly in the context of tumorigenesis, and its peptide derivatives have become important in molecular oncology research. The 19-34 region of SSX2 is of particular interest due to its potential involvement in antigenic recognition and functional domains relevant to cellular signaling and immunological studies.

Epitope Mapping: Researchers frequently employ the SSX2 (19-34) peptide fragment in the mapping of immunogenic epitopes, particularly for the development and validation of antibodies targeting the SSX2 protein. By utilizing this defined sequence, investigators can pinpoint precise antibody-binding regions, enabling the generation of highly specific monoclonal or polyclonal reagents for use in immunohistochemistry, Western blotting, or ELISA-based detection of SSX2 expression in cell and tissue samples. This approach is instrumental in advancing the specificity and sensitivity of immunoassays used in cancer biomarker studies.

T-cell Response Studies: In immunology and cancer research, the SSX2 (19-34) peptide serves as a model antigen for evaluating T-cell recognition and activation. Experimental systems employing this peptide can elucidate the mechanisms by which cytotoxic T lymphocytes recognize SSX2-derived epitopes, providing insights into antigen processing, presentation, and immune surveillance of tumor-associated antigens. Such studies are critical for understanding the cellular immune response to SSX2-expressing tumors and for informing the design of immunotherapeutic strategies.

Peptide-Protein Interaction Analysis: The defined sequence of this SSX2 peptide fragment allows researchers to investigate its interactions with binding partners, such as major histocompatibility complex (MHC) molecules or other regulatory proteins. By studying these interactions in vitro, scientists can dissect the structural and functional determinants of SSX2's role in chromatin remodeling, transcriptional regulation, or antigen presentation. These analyses contribute to a deeper understanding of the molecular pathways involving SSX2 and its peptide domains.

Assay Development: The SSX2 (19-34) peptide is widely used as a standard or control in the development and optimization of analytical assays that detect or quantify SSX2-derived sequences. Its application extends to assay calibration, validation, and troubleshooting, ensuring reproducibility and accuracy in experimental workflows. By providing a reliable reference for signal detection, the peptide supports high-quality data generation in both basic and applied research settings.

Peptide Synthesis and Modification Studies: The chemical properties and sequence of the SSX2 (19-34) fragment make it an ideal substrate for studies involving peptide synthesis, modification, and labeling. Researchers utilize this peptide to explore synthetic methodologies, post-translational modifications, or conjugation techniques, facilitating advancements in peptide chemistry and functionalization. Such investigations enable the development of novel peptide-based reagents, probes, or delivery systems that leverage the unique characteristics of SSX2-derived sequences.

Through these diverse applications, the SSX2 (19-34) peptide fragment plays a pivotal role in advancing molecular, immunological, and biochemical research related to SSX2 and its functional domains. Its defined structure and relevance to cancer-testis antigen biology make it a valuable resource for scientists seeking to unravel the complexities of tumor-associated proteins, immune recognition, and peptide-based assay systems.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

4. Proinsulin C-peptide and insulin: Limited pattern similarities of interest in inter-peptide interactions but no C-peptide effect on insulin and IGF-1 receptor signaling

5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function